Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 67
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Biochim Biophys Acta Bioenerg ; 1861(2): 148134, 2020 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-31825806

RESUMEN

Cytochrome b5 reductase is an enzyme with the ability to generate superoxide anion at the expenses of NADH consumption. Although this activity can be stimulated by cytochrome c and could participate in the bioenergetic failure accounting in apoptosis, very little is known about other molecules that may uncouple the function of the cytochrome b5 reductase. Naphthoquinones are redox active molecules with the ability to interact with electron transfer chains. In this work, we made an inhibitor screening against recombinant human cytochrome b5 reductase based on naphthoquinone properties. We found that 5-hydroxy-1,4-naphthoquinone (known as juglone), a natural naphthoquinone extracted from walnut trees and used historically in traditional medicine with ambiguous health and toxic outcomes, had the ability to uncouple the electron transfer from the reductase to cytochrome b5 and ferricyanide. Upon complex formation with cytochrome b5 reductase, juglone is able to act as an electron acceptor leading to a NADH consumption stimulation and an increase of superoxide anion production by the reductase. Our results suggest that cytochrome b5 reductase could contribute to the measured energetic failure in the erythrocyte apoptosis induced by juglone, that is concomitant with the reactive oxygen species produced by cytochrome b5 reductase.


Asunto(s)
Citocromo-B(5) Reductasa/metabolismo , Eritrocitos/metabolismo , Naftoquinonas/farmacología , Superóxidos/metabolismo , Apoptosis/efectos de los fármacos , Citocromos b5/metabolismo , Transporte de Electrón/efectos de los fármacos , Humanos , NAD/metabolismo
2.
J Exp Ther Oncol ; 11(2): 139-416, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28976137

RESUMEN

OBJECTIVE: Urothelial carcinoma of the bladder is a common malignancy ranked 9th with an estimated 356,600 new cases diagnosed annually worldwide. The study showed the protective effects of Lupeol in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in in vivo experimental model. Forty male healthy wistar rats were selected randomly divided into four groups. Group I rats served as healthy control. Group II rats were treated with BBN (150 mg/gavage/twice a week) for 8 weeks. Group III rats were treated with BBN + Lupeol [ Lupeol (50 mg/kg bw/day) treatment was started 1 week prior to the BBN treatment, and it was orally administered for 8 weeks]. Group IV rats were treated with Lupeol alone (50 mg/kg bw/day) for 8 weeks. All the experimental rats were maintained and euthanized at 32nd week. Serum and bladder tissues were collected and examined for biochemical parameters, serum markers and histopathological evaluation. Preventive (BBN + Lupeol) group modulates the activity of antioxidant enzymes such as Superoxide dismutase, Catalase, Reduced glutathione, Glutathione Peroxidase, Thiobarbituric acid reactive substances (TBARS) and drug metabolizing enzymes such as Cytochrome P450, Cytochrome b5, NADPH Cytochrome c reductase, NADPH- Quinone Oxidoreductase 1 and Glutathione-S-transferase when compared to BBN treated rats. Serological markers such as Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) were significantly (P<0.05) decreased in preventive lupeol treated groups. Lupeol supplementation protects BBN induced bladder carcinogenesis in experimental rats by its antioxidant, anti-inflammatory and antiproliferative properties.


Asunto(s)
Antiinflamatorios/farmacología , Butilhidroxibutilnitrosamina/toxicidad , Carcinogénesis/efectos de los fármacos , Carcinoma de Células Transicionales/enzimología , Triterpenos Pentacíclicos/farmacología , Neoplasias de la Vejiga Urinaria/enzimología , Vejiga Urinaria/efectos de los fármacos , Animales , Antioxidantes , Carcinoma de Células Transicionales/inducido químicamente , Carcinoma de Células Transicionales/metabolismo , Carcinoma de Células Transicionales/patología , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Sistema Enzimático del Citocromo P-450/efectos de los fármacos , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/efectos de los fármacos , Citocromos b5/metabolismo , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Glutatión Transferasa/efectos de los fármacos , Glutatión Transferasa/metabolismo , Masculino , NAD(P)H Deshidrogenasa (Quinona)/efectos de los fármacos , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , NADPH-Ferrihemoproteína Reductasa/efectos de los fármacos , NADPH-Ferrihemoproteína Reductasa/metabolismo , Ratas , Ratas Wistar , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Vejiga Urinaria/enzimología , Vejiga Urinaria/metabolismo , Vejiga Urinaria/patología , Neoplasias de la Vejiga Urinaria/inducido químicamente , Neoplasias de la Vejiga Urinaria/metabolismo , Neoplasias de la Vejiga Urinaria/patología
3.
Ukr Biochem J ; 88(4): 48-56, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-29235764

RESUMEN

The aim of the study was to determine the variations of function in components of monooxygenase system (MOS) of rat Guerin's carcinoma under ω-3 polyunsaturated fatty acids (PUFAs) administration. The activity of Guerin's carcinoma microsomal NADH-cytochrome b5 reductase, the content and the rate of cytochrome b5 oxidation-reduction, the content and the rate of cytochrome Р450 oxidation-reduction have been investigated in rats with tumor under conditions of ω-3 PUFAs administration. ω-3 PUFAs supplementation before and after transplantation of Guerin's carcinoma resulted in the increase of NADH-cytochrome b5 reductase activity and decrease of cytochrome b5 level in the Guerin's carcinoma microsomal fraction in the logarithmic phases of carcinogenesis as compared to the tumor-bearing rats. Increased activity of NADH-cytochrome b5 reductase facilitates higher electron flow in redox-chain of MOS. Under decreased cytochrome b5 levels the electrons are transferred to oxygen, which leads to heightened generation of superoxide (O2•-) in comparison to control. It was shown, that the decrease of cytochrome P450 level in the Guerin's carcinoma microsomal fraction in the logarithmic phases of oncogenesis under ω-3 PUFAs administration may be associated with its transition into an inactive form ­ cytochrome P420. This decrease in cytochrome P450 coincides with increased generation of superoxide by MOS oxygenase chain.


Asunto(s)
Carcinoma/tratamiento farmacológico , Electrones , Ácidos Grasos Omega-3/farmacología , Expresión Génica/efectos de los fármacos , Microsomas/efectos de los fármacos , Sustancias Protectoras/farmacología , Animales , Carcinoma/enzimología , Carcinoma/patología , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromo-B(5) Reductasa/genética , Citocromo-B(5) Reductasa/metabolismo , Citocromos/genética , Citocromos/metabolismo , Citocromos b5/genética , Citocromos b5/metabolismo , Transporte de Electrón/efectos de los fármacos , Femenino , Miembro Posterior , Inyecciones Subcutáneas , Microsomas/enzimología , Trasplante de Neoplasias , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Ratas , Superóxidos/metabolismo
4.
Hum Exp Toxicol ; 34(6): 620-7, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25632966

RESUMEN

This study investigated combined chemopreventive potential of curcumin and resveratrol during benzo(a)pyrene (BP)-induced lung carcinogenesis in mice. The mice were segregated into five groups that included normal control, BP-treated, BP + curcumin-treated, BP + resveratrol-treated, and BP + curcumin + resveratrol-treated groups. A statistically significant increase in the levels of lipid peroxidation (LPO) was observed in the lungs of mice after 22 weeks of single dose of benzo(a)pyrene. Further, BP treatment also resulted in a significant increase in the enzyme activities of aryl hydrocarbon hydroxylase as well as drug-metabolizing enzymes, namely cytocrome P450 and cytochrome b5. On the other hand, reduced glutathione (GSH) levels, the activities of superoxide dismutase (SOD), glutathione reductase (GR), and glutathione-S-transferase (GST) were found to be significantly decreased following BP treatment. Supplementation with curcumin and resveratrol to BP-treated mice significantly decreased the LPO levels, GSH levels, and enzyme activities of drug-metabolizing enzymes. Further, treatment of curcumin and resveratrol to BP-treated mice significantly elevated the activities of SOD, GR, and GST. Histoarchitectural studies showed well-differentiated signs of lung carcinogenesis following BP administration to mice. However, combined treatment with curcumin and resveratrol resulted in a noticeable improvement in the lung histoarchitecture. This study, therefore, concludes that curcumin and resveratrol when supplemented in combination regulate drug-metabolizing enzymes as well as antioxidant enzymes during lung carcinogenesis in mice.


Asunto(s)
Antioxidantes/farmacología , Benzo(a)pireno/toxicidad , Carcinógenos/toxicidad , Curcumina/farmacología , Neoplasias Pulmonares/metabolismo , Estilbenos/farmacología , Animales , Hidrocarburo de Aril Hidroxilasas/metabolismo , Catalasa/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Glutatión/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Pulmón/patología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/patología , Masculino , Ratones , Resveratrol , Superóxido Dismutasa/metabolismo
5.
J Biol Chem ; 289(15): 10345-10358, 2014 Apr 11.
Artículo en Inglés | MEDLINE | ID: mdl-24500710

RESUMEN

Mitochondrial amidoxime reducing component (mARC) proteins are molybdopterin-containing enzymes of unclear physiological function. Both human isoforms mARC-1 and mARC-2 are able to catalyze the reduction of nitrite when they are in the reduced form. Moreover, our results indicate that mARC can generate nitric oxide (NO) from nitrite when forming an electron transfer chain with NADH, cytochrome b5, and NADH-dependent cytochrome b5 reductase. The rate of NO formation increases almost 3-fold when pH was lowered from 7.5 to 6.5. To determine if nitrite reduction is catalyzed by molybdenum in the active site of mARC-1, we mutated the putative active site cysteine residue (Cys-273), known to coordinate molybdenum binding. NO formation was abolished by the C273A mutation in mARC-1. Supplementation of transformed Escherichia coli with tungsten facilitated the replacement of molybdenum in recombinant mARC-1 and abolished NO formation. Therefore, we conclude that human mARC-1 and mARC-2 are capable of catalyzing reduction of nitrite to NO through reaction with its molybdenum cofactor. Finally, expression of mARC-1 in HEK cells using a lentivirus vector was used to confirm cellular nitrite reduction to NO. A comparison of NO formation profiles between mARC and xanthine oxidase reveals similar Kcat and Vmax values but more sustained NO formation from mARC, possibly because it is not vulnerable to autoinhibition via molybdenum desulfuration. The reduction of nitrite by mARC in the mitochondria may represent a new signaling pathway for NADH-dependent hypoxic NO production.


Asunto(s)
Coenzimas/metabolismo , Metaloproteínas/metabolismo , Mitocondrias/enzimología , Proteínas Mitocondriales/metabolismo , Óxido Nítrico Sintasa/metabolismo , Nitrito Reductasas/metabolismo , Oxidorreductasas/metabolismo , Pteridinas/metabolismo , Secuencia de Aminoácidos , Reductasas del Citocromo/metabolismo , Citocromos b5/metabolismo , Transporte de Electrón , Células HEK293 , Humanos , Concentración de Iones de Hidrógeno , Cinética , Datos de Secuencia Molecular , Molibdeno/metabolismo , Cofactores de Molibdeno , Óxido Nítrico/metabolismo , Nitritos/metabolismo , Oxígeno/metabolismo , Proteínas Recombinantes/metabolismo , Homología de Secuencia de Aminoácido , Xantina Oxidasa/metabolismo
6.
Artículo en Inglés | MEDLINE | ID: mdl-24051281

RESUMEN

Uranium is harmful to human health due to its radiation damage and the ability of uranyl ion (UO2(2+)) to interact with various proteins and disturb their biological functions. Cytochrome b5 (cyt b5) is a highly negatively charged heme protein and plays a key role in mediating cytochrome c (cyt c) signaling in apoptosis by forming a dynamic cyt b5-cyt c complex. In previous molecular modeling study in combination with UV-Vis studies, we found that UO2(2+) is capable of binding to cyt b5 at surface residues, Glu37 and Glu43. In this study, we further investigated the structural consequences of cyt b5 and cyt c, as well as cyt b5-cyt c complex, upon uranyl binding, by fluorescence spectroscopic and circular dichroism techniques. Moreover, we proposed a uranyl binding site for cyt c at surface residues, Glu66 and Glu69, by performing a molecular modeling study. It was shown that uranyl binds to cyt b5 (KD=10 µM), cyt c (KD=87 µM), and cyt b5-cyt c complex (KD=30 µM) with a different affinity, which slightly alters the protein conformation and disturbs the interaction of cyt b5-cyt c complex. Additionally, we investigated the functional consequences of uranyl binding to the protein surface, which decreases the inherent peroxidase activity of cyt c. The information of uranyl-cyt b5/cyt c interactions gained in this study likely provides a clue for the mechanism of uranyl toxicity.


Asunto(s)
Citocromos b5/metabolismo , Citocromos c/metabolismo , Uranio/metabolismo , Animales , Bovinos , Citocromos b5/química , Citocromos c/química , Caballos , Humanos , Iones , Cinética , Modelos Moleculares , Peroxidasa/metabolismo , Unión Proteica , Espectrometría de Fluorescencia , Uranio/química
7.
Indian J Biochem Biophys ; 50(2): 105-13, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23720884

RESUMEN

The modulation in biochemical status of skin and hepatic tissue at the time point of commencement of promotion stage of skin carcinogenesis in mice and its intervention with aqueous Azadirachta indica leaf extract (AAILE) were investigated. 7,12-Dimethylbenz(a)anthracene (DMBA, 500 nmol/100 ul of acetone) was applied topically for 2 weeks (twice weekly), followed by phorbol-12-myristate-13-acetate (TPA, 1.7 nmol/100 ul) twice weekly for 6 weeks on the depilated skin of mice and AAILE was administered orally at a dose level of 300 mg/kg body wt thrice a week for 10 weeks. DMBA/TPA treatment upregulated the phase I enzymes in skin and hepatic tissue, as revealed by the increased cytochrome P450 (CYP) and cytochrome b5 (cyt b5) levels and aryl hydrocarbon hydroxylase (AHH) activity when compared to the control group and differentially modulated the activities of phase II enzymes like glutathione-s-transferase (GST), DT-diaphorase (DTD) and uridine diphosphate glucuronosyltransferase (UDP-GT). AAILE treatment decreased the DMBA/TPA-induced increase in cutaneous CYP level and enhanced the DTD and UDP-GT activities when compared with DMBA/TPA group. In the hepatic tissue of AAILE + DMBA/TPA group, an increase in UDP-GT activity was observed when compared to DMBA/TPA group. DMBA/TPA treatment did not alter the skin lipid peroxidation (LPO) level when compared to control group, however, in the animals that received AAILE treatment along with DMBA/TPA, a significant increase in LPO was observed when compared to control group. This was associated with a decrease, in cutaneous reduced glutathione (GSH) level of AAILE + DMBA/TPA group. Enhanced LPO level was observed in the hepatic tissue of DMBA/TPA and AAILE + DMBA/TPA groups when compared to control group. However, no alteration was observed in their hepatic GSH levels. The micronuclei score in hepatic tissue did not exhibit significant inter-group differences. The results of the present study suggest that apart from skin, liver may be affected during DMBA/TPA-induced skin tumorigenesis. AAILE treatment has the ability to modulate these changes potentially influencing the process of tumor formation. These findings seem to be important to carcinogenesis and its intervention with anti-cancer agents.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/farmacología , Azadirachta/química , Hígado/metabolismo , Neoplasias Experimentales/inducido químicamente , Extractos Vegetales/farmacología , Neoplasias Cutáneas/tratamiento farmacológico , Piel/metabolismo , Animales , Antineoplásicos/farmacología , Antioxidantes/metabolismo , Transformación Celular Neoplásica , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Regulación Neoplásica de la Expresión Génica , Glutatión Transferasa/metabolismo , Peroxidación de Lípido , Hígado/efectos de los fármacos , Masculino , Ratones , Pruebas de Micronúcleos , Fitoterapia/métodos , Hojas de la Planta , Piel/efectos de los fármacos , Neoplasias Cutáneas/inducido químicamente , Acetato de Tetradecanoilforbol/farmacología , Xenobióticos/química
8.
Zhongguo Zhong Yao Za Zhi ; 35(3): 348-51, 2010 Feb.
Artículo en Chino | MEDLINE | ID: mdl-20423003

RESUMEN

OBJECTIVE: To study the effects of salvianolic acid A on content of cytochrome P450,cytochrome b5 and CYP1A2, CYP2E1 activities of rats. METHOD: The rats were randomly divided into two groups and each group contained 5 male rats and 5 female rats. One is control group, another is dosage group. The dosage group was injected salvianolic acid A into a rat tail vein at doses of 20 mg x kg(-1) x d(-1) for 5 days. The control group was injected placebo into a rat tail vein at the same doses as the dosage group. The content of cytochrome P450 and cytochrome b5 of rats were assayed using UV and CYP1A2, CYP2E1 activities were evaluated using probe substrate. RESULT: After salvianolic acid A was injected into rats tail vein for 5 days, the total content of cytochrome P450 and cytochrome b5 and CYP1A2 and CYP2E1 activities have no statistical significance of differences than the control group. CONCLUSION: Salvianolic acid A has no effects on CYP1A2 and CYP2E1 activities, indicating that there is no internation between salvianolic acid A and the drugs metabolized by CYP1A2 or CYP2E1.


Asunto(s)
Ácidos Cafeicos/farmacología , Sistema Enzimático del Citocromo P-450/metabolismo , Lactatos/farmacología , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo , Animales , Cromatografía Líquida de Alta Presión , Citocromo P-450 CYP1A2/metabolismo , Citocromo P-450 CYP2E1/metabolismo , Citocromos b5/metabolismo , Femenino , Masculino , Ratas , Ratas Sprague-Dawley
9.
Asian Pac J Cancer Prev ; 11(6): 1833-8, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21338242

RESUMEN

A large number of active principles from traditional medicinal plants have been reported to have chemopreventive properties. In the present study, therapeutic efficacy of an aqueous extract of Indigofera aspalathoides against growth of transplanted experimental fibrosarcomas in Wistar strain male albino rats was tested. Tumors which appeared about six weeks after implantation were highly localized and were maintained by serial transplantation. Rats were divided into four groups. Group I served as normal control animals. Group II were fibrosarcoma bearing animals. Group III were animals with fibrosarcoma treated with Indigofera aspalathoides aqueous extracts at a dose of 250 mg/kg. b. w. per day for 30 days. Group IV animals were treated with aqueous extract of Indigofera aspalathoides alone. Reduction in tumor weight was noted in Group III as compared to II. The levels of cytochrome C in liver and kidney, the levels of cytochrome P450 and cytochrome b5 in liver microsomes, phase I biotransformation enzymes NADPH-cytochrome P450, NADPH-cytochrome b5, and aniline hydroxylase, and the phase II enzymes glutathione-S-transferase and UDP glucuronyl transferase indicated that their modulation played a role in the therapeutic efficacy of Indigofera aspalathoides against experimental fibrosarcoma.


Asunto(s)
Inactivación Metabólica , Indigofera/química , Fitoterapia , Extractos Vegetales/uso terapéutico , Sarcoma Experimental/prevención & control , Xenobióticos/metabolismo , Anilina Hidroxilasa/metabolismo , Animales , Biotransformación , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Glucuronosiltransferasa/metabolismo , Glutatión Transferasa/metabolismo , Masculino , Metilcolantreno , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Ratas , Ratas Wistar , Sarcoma Experimental/inducido químicamente , Sarcoma Experimental/patología
10.
Zhongguo Zhong Yao Za Zhi ; 34(4): 447-9, 2009 Feb.
Artículo en Chino | MEDLINE | ID: mdl-19459309

RESUMEN

OBJECTIVE: To study the effect of the volatile oil from nutmeg on liver microsomal cytochrome P450 in mice. METHOD: Mice were administered the volatile oil from nutmeg at 0.4, 0.8 and 1.2 mg x g(-1), respectively, twice a day for 10 days. And then, the contents of liver microsomal cytochrome P450 (CYP), cytochrome b5 (Cytb5), MDA and GST in serum were examined by UV chromatography method. RESULT: The contents of liver CYP, Cytb5 and GST in serum were increased significantly (P < 0.01) and the contents of MDA was reduced significantly (P < 0.01). CONCLUSION: The volatile oil from nutmeg showed induction effect on the hepatic microsomal CYP in mice.


Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Microsomas Hepáticos/efectos de los fármacos , Myristica/química , Aceites Volátiles/farmacología , Animales , Citocromos b5/metabolismo , Medicamentos Herbarios Chinos/farmacología , Femenino , Regulación Enzimológica de la Expresión Génica , Masculino , Ratones , Microsomas Hepáticos/enzimología , Aceites de Plantas/farmacología
11.
Mol Cell Biochem ; 331(1-2): 135-43, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19449198

RESUMEN

Lung cancer is currently a leading cause of death all over the world. Environmental risk factors, particularly genotoxic chemicals such as polycyclic aromatic hydrocarbons (PAH), are likely to account for a much higher mortality. Xenobiotic metabolizing enzymes are potentially chief determinants in both the susceptibility to the mutagenic effects of chemical carcinogens and in the response of tumors to chemotherapy. The well-known carcinogen benzo(a)pyrene (B(a)P) of PAH family was given orally (50 mg/kg body weight) to induce lung cancer in Swiss albino mice. B(a)P induction altered the levels of cytochromes (P450, b5), activities of phase I biotransformation enzymes (NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase and epoxide hydrolase), phase II enzymes (glutathione-S-transferase, UDP-glucuronyl transferase and DT-diaphorase), and the levels of serum tumor markers. Treatment with capsaicin (CAP) (10 mg/kg body weight) to the lung carcinoma mice restored back the activities of phase I and II biotransformation enzymes and the levels of tumor markers to near normalcy. The above findings were substantiated by immunoblotting and immunohistochemical analysis of cytochrome P450 1A1 (CYP1A1) in the lung tissues. Our present study unravels that CAP can effectively detoxify the carcinogens which discloses its anti-carcinogenic effect during experimental lung cancer.


Asunto(s)
Biomarcadores de Tumor/sangre , Capsaicina/uso terapéutico , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/enzimología , Neoplasias Experimentales/tratamiento farmacológico , Neoplasias Experimentales/enzimología , Xenobióticos/metabolismo , Animales , Capsaicina/farmacología , Citocromo P-450 CYP1A1/metabolismo , Citocromos b5/metabolismo , Ensayos de Selección de Medicamentos Antitumorales , Inmunohistoquímica , Pulmón/efectos de los fármacos , Pulmón/enzimología , Pulmón/patología , Neoplasias Pulmonares/sangre , Masculino , Fase I de la Desintoxicación Metabólica , Fase II de la Desintoxicación Metabólica , Ratones , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Neoplasias Experimentales/sangre
12.
Protein Expr Purif ; 62(2): 171-8, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18765284

RESUMEN

A wheat germ cell-free extract was used to perform in vitro translation of human stearoyl-CoA desaturase in the presence of unilamelar liposomes, and near complete transfer of the expressed integral membrane protein into the liposome was observed. Moreover, co-translation of the desaturase along with human cytochrome b(5) led to transfer of both membrane proteins into the liposomes. A simple, single step purification via centrifugation in a density gradient yielded proteoliposomes with the desaturase in high purity as judged by capillary electrophoresis. After in vitro reconstitution of the non-heme iron and heme active sites, the function of the reconstituted enzyme complex was demonstrated by conversion of stearoyl-CoA to oleoyl-CoA. This simple translation approach obviates the use of detergents or other lipids to stabilize and isolate a catalytically active integral membrane enzyme. The applicability of cell-free translation to the assembly and purification of other integral membrane protein complexes is discussed.


Asunto(s)
Biosíntesis de Proteínas , Estearoil-CoA Desaturasa/biosíntesis , Estearoil-CoA Desaturasa/aislamiento & purificación , Triticum/metabolismo , Animales , Secuencia de Bases , Catálisis , Sistema Libre de Células/efectos de los fármacos , Citocromos b5/metabolismo , Detergentes/farmacología , Electroforesis Capilar , Vectores Genéticos/genética , Humanos , Isoenzimas/aislamiento & purificación , Liposomas/aislamiento & purificación , Ratones , Datos de Secuencia Molecular , Mycobacterium/enzimología , Extractos Vegetales/análisis , Biosíntesis de Proteínas/efectos de los fármacos
13.
Chem Biol Interact ; 172(3): 224-34, 2008 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-18336807

RESUMEN

Oral cancer is one of the most common cancers in the world. Drugs can modulate the expression of drug metabolizing enzymes and are useful in chemoprevention as well as therapy in cancer. 4-Nitroquinoline 1-oxide (4-NQO) is used to induce oral cancer in the present study. In the present investigation, the effect of green tea polyphenols (GTP) on the activities of cytochrome b5, cytochrome P450, cytochrome b5 reductase (cyt b5 R), cytochrome P450 reductase (cyt P450 R), arryl hydrocarbon hydroxylase (AHH), DT-diaphorase (DTD)(Phase I enzymes) and glutathione-S-transferase (GST) and UDP-glucuronyl transferase (UDP-GT) (Phase II enzymes) were assessed in tongue and oral cavity. In induced rats, there was a decrease in the activity of Phase II enzymes and an increase in the activity of Phase I enzymes. On supplementation of GTP by both simultaneous and post treatment mode (200mg/kg) there was a significant increase in the activity of GST and UDP-GT and a significant decrease in the activity of Phase I enzymes. There was a significant decline in the number of tumors, tumor volume and oral squamous cell carcinoma in both simultaneous and post GTP treated animals relative to 4-NQO induced animals; on comparing simultaneous and post GTP treated animals the number of tumors, tumor volume and oral squamous cell carcinoma was significantly reduced in post treated animals. Thus inhibition of Phase I enzymes could be attributed to the protective efficacy of GTP which deactivates carcinogen and GTP induced the expression of Phase II enzymes that detoxifies the 4-NQO. It can be proposed that GTP plays role as a detoxifying agent by which its modulating role prevented/inhibited the formation of tumor.


Asunto(s)
4-Nitroquinolina-1-Óxido/uso terapéutico , Antineoplásicos/uso terapéutico , Neoplasias de la Boca/prevención & control , Té/química , 4-Nitroquinolina-1-Óxido/farmacología , Animales , Antineoplásicos/química , Antineoplásicos/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Hidrocarburo de Aril Hidroxilasas/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromo-B(5) Reductasa/metabolismo , Citocromos b5/metabolismo , Relación Dosis-Respuesta a Droga , Flavonoides/química , Flavonoides/farmacología , Flavonoides/uso terapéutico , Glucuronosiltransferasa/metabolismo , Glutatión Transferasa/metabolismo , Masculino , Neoplasias de la Boca/inducido químicamente , Neoplasias de la Boca/tratamiento farmacológico , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Fenoles/química , Fenoles/farmacología , Fenoles/uso terapéutico , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Polifenoles , Ratas , Ratas Wistar
14.
Indian J Exp Biol ; 45(4): 359-66, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17477308

RESUMEN

Considering the hepatoprotective properties of Azadirachta indica, the present study was designed to evaluate its preventive effects against diethylnitrosamine (NDEA) induced hepatotoxicity in male Balb/c mice. Exposure of NDEA caused a significant increase in micronucleated cell score, lipid peroxidation levels (LPO) and activity of lactate dehydrogenase (LDH). A significant decrease in reduced glutathione (GSH) contents and activity of glutathione-S-transferase (GST) was also observed upon NDEA treatment, whereas their activities of cytochrome P450 and cytochrome b5 showed non-significant alterations. Aqueous A. indica leaf extract (AAILE) pretreatment showed protective effects against NDEA induced toxicity by decreasing the frequency of micronucleated cell, levels of LPO and LDH activity. Also, a decreased activity of GST, cytochrome P450 and an increased activity of cytochrome b5, GSH contents was observed when AAILE pretreated mice were injected with NDEA. Only AAILE treatment caused a noticeable decrease in the frequency of micronuclei, activity of cytochrome P450 and cytochrome b5, but a significant increase in the activity of GST and GSH contents, whereas, non significant alterations were observed in the activity of LDH and levels of LPO. Significance of these observations with respect to hepatoprotective efficacy of A. indica has been discussed in the present manuscript.


Asunto(s)
Alquilantes/antagonistas & inhibidores , Azadirachta/química , Dietilnitrosamina/antagonistas & inhibidores , Hepatopatías/prevención & control , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Alquilantes/toxicidad , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Dietilnitrosamina/toxicidad , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Hígado/patología , Hepatopatías/patología , Masculino , Ratones , Pruebas de Micronúcleos , Hojas de la Planta/química
15.
Br Poult Sci ; 48(1): 90-7, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17364546

RESUMEN

1. Effects of dietary supplementation of astaxanthin (Ax) provided from Phaffia rhodozyma on lipid peroxidation, hepatic drug metabolism, antibody titres to sheep red blood cells (SRBC) and splenocyte proliferation to mitogens were determined in male broiler chicks. 2. Chicks, one week old, were given diets with or without oxidised fat (0 or 3.7 meq of peroxide value (POV)/kg diet) and/or Ax (0 or 100 mg/kg diet) for 14 d, ad libitum. 3. Lipid peroxidation, estimated by 2-thiobarbituric acid reactants values in liver, spleen, heart, plasma and hepatic microsomes, were increased by feeding a diet containing oxidised fat (P<0.05) but were not affected by Ax feeding. 4. Cytochrome P-450 contents in hepatic microsome tended to be increased by feeding Ax. 5. Anti-SRBC titre was not affected by oxidised fat or Ax feeding, while plasma immunogloblin (Ig) G concentration was increased by Ax feeding but was not affected by oxidised fat feeding. 6. When chicks were fed on the diet without oxidised fat, Ax enhanced splenocyte proliferation stimulated by both concanavalin A and pokeweed mitogen, while in chicks fed on a diet containing oxidised fat, Ax reduced the proliferation (P<0.01 for Ax and oxidised fat interaction). 7. The results indicated that dietary supplementation of Ax from Phaffia rhodozyma had an impact on T cell proliferation and Ig G production as a part of acquired immunity, but was not effective in preventing lipid peroxidation in male broiler chicks.


Asunto(s)
Pollos/metabolismo , Grasas de la Dieta/administración & dosificación , Suplementos Dietéticos , Hígado/metabolismo , Animales , Pollos/inmunología , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Grasas de la Dieta/metabolismo , Inmunoglobulina G/sangre , Peroxidación de Lípido/efectos de los fármacos , Hígado/enzimología , Masculino , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Xantófilas/administración & dosificación , Xantófilas/metabolismo
16.
Toxicol Lett ; 169(1): 26-33, 2007 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-17194553

RESUMEN

The present study investigated the protective effects of zinc in attenuating the altered activities of drug metabolizing enzymes in the livers of rats intoxicated with chlorpyrifos. Male Sprague-Dawley rats received oral chlorpyrifos treatment (at a dose level of 13.5 mg/kg body weight in corn oil every alternate day), zinc supplementation alone (at a dose level of 227 mg/l in drinking water), or combined chlorpyrifos plus zinc treatments for a total duration of 8 weeks. The effects of different treatments were studied on the specific activities of various drug metabolizing enzymes including cytochrome P(450), cytochrome b(5), NADPH cytochrome-c-reductase, NADH cytochrome-c-reductase, aminopyrene-N-demethylase (APD) and aromatic hydrocarbon hydroxylase (AHH). Additionally, serum zinc levels were also determined in each of the treatment groups at the end of the study. Chlorpyrifos treatment resulted in a significant decrease in the serum zinc concentrations. Analogous to these changes, we observed significant depression in the activities of majority of the drug metabolizing enzymes investigated in the present study, except for AHH, where the decrease in enzyme activity was not statistically significant. However, zinc treatment to chlorpyrifos treated animals effectively restored the depressed serum zinc levels to within normal limits. Similarly, co-administration of zinc to chlorpyrifos intoxicated animals normalized the enzymatic activities of cytochrome P(450), NADPH cytochrome-c-reductase and NADH cytochrome-c-reductase within normal range. Collectively, these findings suggest that zinc plays an important role in regulating the hepatic activities of drug metabolizing enzymes in chlorpyrifos intoxicated animals, although it remains to be determined whether such protective effects of zinc are regulated directly, or through some indirect mechanism.


Asunto(s)
Cloropirifos/toxicidad , Insecticidas/toxicidad , Hígado/enzimología , Oxigenasas de Función Mixta/metabolismo , Zinc/farmacología , Aminopirina N-Demetilasa/metabolismo , Animales , Peso Corporal/efectos de los fármacos , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Hígado/efectos de los fármacos , Masculino , NADH Deshidrogenasa/metabolismo , NADPH-Ferrihemoproteína Reductasa/metabolismo , Preparaciones Farmacéuticas/metabolismo , Ratas , Ratas Sprague-Dawley , Espectrofotometría Atómica , Zinc/sangre
17.
Phytother Res ; 20(10): 889-95, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16909440

RESUMEN

In the present investigation, the effects of aqueous Azadirachta indica leaf extract (AAILE) on (3)H-benzo(a)pyrene-DNA [(3)H-B(a)P-DNA] adduct formation, the status of biotransformation enzymes and reduced glutathione (GSH) content were evaluated in the forestomach and liver of Balb/c mice. Two weeks of AAILE treatment reduced the (3)H-B(a)P-DNA adduct levels by 31.6% in forestomach tissue. Similarly, (3)H-B(a)P-DNA adduct levels were decreased by 34.7% in the liver of AAILE treated mice compared with their control counterparts. After AAILE treatment, the cytochrome P450 content decreased, whereas the GSH content increased significantly in the hepatic tissue. In the forestomach as well as in the liver, the cytochrome b5 content declined, whereas an increase in glutathione-S-transferase (GST) activity was observed in both tissues. These observations suggested that AAILE may have reduced the metabolic activation of (3)H-B(a)P with enhanced detoxification of its active metabolites, hence the observed decrease in the levels of (3)H-B(a)P-DNA adducts. These molecular and biochemical modulations observed at the initiation phase of carcinogenesis seems to be significant and could be correlated with the chemopreventive effects of A. indica against B(a)P induced forestomach tumorigenesis.


Asunto(s)
Antimutagênicos/farmacología , Azadirachta/química , Benzo(a)pireno/metabolismo , Aductos de ADN/metabolismo , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Estómago/efectos de los fármacos , Animales , Antimutagênicos/química , Antimutagênicos/aislamiento & purificación , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Mucosa Gástrica/metabolismo , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Hígado/metabolismo , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta/química
18.
Comp Biochem Physiol C Toxicol Pharmacol ; 143(3): 349-54, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16720105

RESUMEN

Propolis, a natural beehive product has been known for centuries for a variety of beneficial traditional medicinal properties. The present study was conducted to ascertain the antineoplastic potential of propolis along with paclitaxel against experimental mammary carcinogenesis. Female Sprague Dawley rats at 55 days of age were treated with dimethylbenz(a)anthracene to induce breast cancer. Paclitaxel at a dose of 33 mg/kg body mass intraperitoneally and propolis 50 mg/kg body weight orally was administered to the experimental animals, immediately after the carcinogen treatment and continued until the termination of the study. At the end of the treatment activities of phase I and II xenobiotic metabolizing enzymes and liver marker enzymes were measured. A significant increase in carcinogen activating enzymes, cytochrome P(450), cytochrome b(5) and NADPH cytochrome C reductase with concomitant decrease in phase II enzymes, glutathione transferase and UDP-glucuronyl transferase were observed in animals with mammary cancer. Furthermore there was a significant decrease in alanine aminotransferase, aspartate aminotransferase with a sharp increase in alkaline phosphatase, acid phosphatase and 5' nucleotidase. Propolis treatment caused the activity of these enzymes return to almost normal control levels, indicating the protective effect of propolis against dimethyl benz(a) anthracene induced carcinogenesis. On the basis of the observed results propolis can be considered a promising chemotherapeutic agent and can be administered as an adjuvant with paclitaxel chemotherapy.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Hígado/efectos de los fármacos , Neoplasias Mamarias Experimentales/enzimología , 5'-Nucleotidasa/sangre , 5'-Nucleotidasa/metabolismo , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Fosfatasa Ácida/sangre , Fosfatasa Ácida/metabolismo , Fosfatasa Alcalina/sangre , Fosfatasa Alcalina/metabolismo , Animales , Antineoplásicos/administración & dosificación , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Femenino , Hígado/enzimología , Neoplasias Mamarias Experimentales/inducido químicamente , Neoplasias Mamarias Experimentales/tratamiento farmacológico , NADPH-Ferrihemoproteína Reductasa/metabolismo , Paclitaxel/administración & dosificación , Própolis/administración & dosificación , Ratas , Ratas Sprague-Dawley , Transferasas/sangre , Transferasas/metabolismo
19.
J Exp Clin Cancer Res ; 24(2): 223-30, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16110755

RESUMEN

Chemoprevention by medicinal plants is a promising approach for controlling cancer. There is substantial evidence to indicate that chemopreventive agents exert their anticarcinogenic effects by modulation of phase I and phase II xenobiotic-metabolizing enzymes. Therefore, we examined the chemopreventive potential of ethanolic neem leaf extract (ENLE) on 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis. Hamsters were divided into four groups of six animals each. The right buccal pouches of animals in Group I were painted with 0.5 per cent DMBA in liquid paraffin three times per week. Animals in Group 2 painted with DMBA as in group 1, received in addition, intragastric administration of ENLE at a concentration of 200 mg/kg bw three times per week on days alternate to DMBA application. Group 3 was given ENLE alone. Animals in Group 4 served as controls. All animals were killed after an experimental period of 14 weeks. Five out of six hamsters painted with DMBA alone developed squamous cell carcinomas in the buccal pouch. The HBP tumours showed an increase in phase I carcinogen activation (cytochrome P450 and b5) and phase II detoxification enzyme (glutathione-S-transferase, DT-diaphorase and NADPH-diaphorase) activities. In the liver of tumour-bearing animals, enhanced cytochrome P450 and b5 levels were accompanied by a decrease in phase II detoxification enzyme activities. Administration of ENLE effectively suppressed DMBA-induced HBP tumours, decreased cytochrome P450 and b5 levels, and enhanced phase II enzyme activities in the pouch and liver. Our results suggest that the modulation of DMBA metabolism is a possible mechanism for the chemopreventive effects of ethanolic neem leaf extract.


Asunto(s)
Etanol/farmacología , Neoplasias Experimentales/enzimología , Fitoterapia/métodos , Xenobióticos/metabolismo , 9,10-Dimetil-1,2-benzantraceno , Animales , Anticarcinógenos/farmacología , Carcinógenos , Mejilla , Cricetinae , Sistema Enzimático del Citocromo P-450/metabolismo , Citocromos b5/metabolismo , Modelos Animales de Enfermedad , Glutatión Transferasa/metabolismo , Hígado/enzimología , Neoplasias/prevención & control , Neoplasias Experimentales/inducido químicamente , Hojas de la Planta/metabolismo , Factores de Tiempo
20.
J Biol Chem ; 280(11): 10196-201, 2005 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-15640159

RESUMEN

The enzyme CYP17 primarily regulates androgen production by mediating four reactions: conversion of pregnenolone and progesterone to 17-hydroxypregnenolone and 17-hydroxyprogesterone, respectively (17alpha-hydroxylase activity), followed by conversion of the 17-hydroxylated steroids to dehydroepiandrosterone and androstenedione, respectively (17,20-lyase activity). Most mammalian CYP17 isoforms have high 17alpha-hydroxylase relative to 17,20-lyase activities and preferentially mediate one of the two 17,20-lyase reactions. In contrast, Xenopus laevis CYP17 potently regulates all four reactions in the frog ovary. CYP17 isoforms generally rely on the cofactor cytochrome b(5) for the 17,20-lyase reaction, suggesting that the high lyase activity of Xenopus CYP17 might be due to a lesser dependence on b(5). The kinetics of Xenopus CYP17 expressed in yeast microsomes were therefore examined in the absence and presence of Xenopus on human b(5). Xenopus CYP17 mediated both 17,20-lyase reactions in the absence of b(5), confirming that the activity did not require b(5). However, both Xenopus and human b(5) slightly enhanced Xenopus CYP17-mediated lyase activity, indicating that the enzyme was still at least partially responsive to b(5). Surprisingly, only the human b(5) cofactor enhanced human CYP17-mediated lyase activity, implying that the human enzyme had more specific cofactor requirements than Xenopus CYP17. Studies using human/Xenopus chimeric b(5) proteins revealed that human b(5) residues 16-41 were important for the specific regulation of the lyase activity of HuCYP17, possibly serving as an interacting domain with the enzyme. CYP17 may therefore have evolved from a general producer of sex steroids in lower vertebrates to a more tightly regulated producer of both sex steroids and glucocorticoids in mammals.


Asunto(s)
Andrógenos/biosíntesis , Citocromos b5/metabolismo , Esteroide 17-alfa-Hidroxilasa/fisiología , Secuencia de Aminoácidos , Animales , ADN Complementario/metabolismo , Relación Dosis-Respuesta a Droga , Femenino , Hongos/metabolismo , Glucocorticoides/metabolismo , Humanos , Cinética , Microsomas/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Ovario/metabolismo , Isoformas de Proteínas , Estructura Secundaria de Proteína , Proteínas Recombinantes de Fusión/metabolismo , Programas Informáticos , Especificidad de la Especie , Esteroide 17-alfa-Hidroxilasa/metabolismo , Xenopus laevis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA